| Business Summary | | i-STAT
Corporation
develops,
manufactures
and
markets
medical
diagnostic
products
for
blood
analysis
that
provide
healthcare
professionals
with
immediate
and
accurate
critical
diagnostic
information
at
the
point
of
patient
care.
The
Company's
i-STAT
System
provides
accurate
and
reliable
blood
test
results
more
quickly
and
more
simply
than
the
most
advanced
clinical
laboratory
equipment.
The
i-STAT
System
consists
of
portable,
hand-held
analyzers
and
single-use,
disposable
cartridges,
each
of
which
simultaneously
performs
different
combinations
of
commonly
ordered
blood
tests
in
approximately
two
minutes.
The
i-STAT
System
uses
a
simple,
one-step
procedure,
the
results
of
which
can
be
easily
linked
by
infrared
transmission
to
a
healthcare
provider's
information
system. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | i-STAT
develops,
manufactures
and
markets
medical
diagnostic
products
for
blood
analysis
that
provide
healthcare
professionals
with
immediate
and
accurate
critical
diagnostic
information.
For
the
six
months
ended
6/30/01,
revenues
increased
3%
to
$26.7
million.
Net
loss
rose
from
$8.2
million
to
$18
million.
Revenues
benefited
from
an
increase
in
cartridge
shipment
volume.
Higher
loss
reflects
the
settlement
for
a
patent
infringement
lawsuit. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| J. Robert Buchanan, M.D., 73 Chairman | -- | William Moffitt, 54 Pres,
CEO, | $408K | Roger Mason, 52 CFO,
VP-Fin., Treasurer | 271K | Michael Zelin, 40 Exec.
VP, CTO | 278K | Noah Kroloff, 38 VP
of International Sales and Marketing and Corp. Devel. | 191K | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|